Patient Compliance

All independent directors of MUHC quit, blaming Quebec health minister
Examining treatments: managing painful diabetic neuropathy

Diabetic neuropathies are a disabling condition and the most common form has been estimated to occur in at least 20% of people with type 1 diabetes after 20 years of disease duration, and 10-15% of newly diagnosed patients with type 2 diabetes, increasing to 50% after. There are several treatment options for those who present with symptoms.
Why so many Canadians seek out-of-country healthcare
Psychiatric illness and homelessness common in emergency sunburn cases

Study also reveals sun protection counselling done in only one-third of ER visits
The case for vitamin A and diabetes

Study shows this vitamin may improve function of insulin-producing cells
Updated Canadian guidelines for managing primary dysmenorrhea

Outline nonhormonal and hormonal therapies, other therapies and surgical procedures
Proton pump inhibitors linked to increased mortality

May be time to restrict use of the drugs, say researchers
Laxative recall expanded

Further to a recent recall of RestoraLAX 45+10, Health Canada is advising Canadians that Bayer Inc. is expanding its voluntary recall to include specific lots of RestoraLAX 30+7 Bonus Packs due to a potential choking hazard.

Techs weigh in on OCP plan for medication safety